+ 0.00
+ 0%
+ 0.00
+ 0%
+ 0.00
+ 0%
+ 0.00
+ 0%
+ 0.00
+ 0%

Some Of The Most Notable Changes This 13F Season

November 15, 2016 3:06 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Some Of The Most Notable Changes This 13F Season

Having passed the SEC deadline for Q3 13F filings, most large hedge funds and investment management firms already disclosed their long equity positions as of September 30.

While aggregate data and stats aren't out yet, Benzinga wanted to share a quick look into some of the most notable moves made by top money managers between July and September.

Apple Inc. (NASDAQ: AAPL) still counts Warren Buffett’s Berkshire Hathaway and Morgan Stanley among its largest investors.

David Shaw’s D.E. Shaw boosted its exposure by 178 percent, to 6,683,396 shares (plus options), and Tiger Global Management by 161 percent to 3.6 million shares.

Dan Loeb’s Third Point initiated a stake comprising 2.5 million shares, while Jim Simons’ Renaissance Technologies sold all of its 1,096,033 shares.

Alphabet Inc (NASDAQ: GOOGL) (NASDAQ: GOOG) also counted on the support of Third Point, Tiger Global and D.E. Shaw, each of which held several hundred million dollars in the tech giant as of September 30.

A noteworthy move was that of Ken Griffin’s Citadel Advisors, which initiated a stake comprising 635,345 Class A (GOOGL) shares, valued at more than half a billion dollars by the end of the quarter, while trimming its exposure to the Class C (GOOG) stock by 96 percent, to 1,293 shares. Steve Cohen’s Point 72 also opened a position comprising 111,491 Class C shares and 419,288 Class A shares.

Back to Third Point, the fund started a new, 2.6 million shares stake in Alibaba Group Holding Ltd (NYSE: BABA) over Q2, while trimming its exposure to Allergan plc Ordinary Shares (NYSE: AGN) by 1,115,000 shares (or 22 percent), keeping 3,785,000 shares or $871 million in stock. Tiger Global also initiated a position comprising 5,373,553 shares in Alibaba between July and September.

David Einhorn’s Greenlight Capital bought into two new stocks, sold out of 11, increased its exposure to 6 more, and trimmed it in 20 companies. Noteworthy was its move in Calpine Corporation (NYSE: CPN), where it boosted its participation by 98 percent, to 11,239,800 shares, or about $142 million in stock. Exited positions included Perrigo Company plc Ordinary Shares (NYSE: PRGO), Liberty Global plc – Class C Ordinary Shares (NASDAQ: LILAK) and Vodafone Group Plc (ADR) (NASDAQ: VOD).

Another very popular stock, Bank of America Corp (NYSE: BAC), saw Andreas Halvorsen’s Viking Global open a position comprising 25,110,973 million shares over the third quarter. Renaissance Technologies also jumped into the list of investors, acquiring 7,677,366 shares. Big sellers included D.E. Shaw, which disposed of 13,856,219 shares, keeping 8,501,517, and Two Sigma Investments, which got rid of all of its 683,953 shares.

Williams Companies Inc (NYSE: WMB) had the honor or receiving George Soros’ Soros Fund Management as a new investor, after it bought 3,171,321 shares over Q3. On the other hand, one of the largest positions closed out was that at Gaming and Leisure Properties Inc (NASDAQ: GLPI).

Finally, there’s Phillips 66 (NYSE: PSX), which saw Berkshire Hathaway increase its stake by 2 percent, to 80,689,892 shares, or about $6.5 billion in stock.

Related Articles

Warren Buffett Says Berkshire's Apple Investment Shows The 'Power Of Repurchases'

Berkshire Hathaway Inc (NYSE: BRK-A) (NYSE: BRK-B) CEO Warren Buffett over the weekend read more

Tesla Gets Street-High $810 Price Target From Morgan Stanley

Despite rising more than 700% over the past year, Tesla Inc (NASDAQ: TSLA) is getting a bullish call and new Street-high price target. read more

Apple, Tesla, DocuSign And 12 Others In Morgan Stanley's 'Secular Growth Stocks' Lineup For 2021

Morgan Stanley has released its “Secular Growth Stocks” list for 2021, as reported by CNBC on Wednesday. read more

Warren Buffett's Berkshire Bets On These Four Drugmakers Amid Pandemic

Berkshire Hathaway Inc (NYSE: BRK-A) (NYSE: BRK-B) Chairman Warren Buffett has invested in four large drugmakers as the world faces yet another wave of the raging COVID-19 pandemic. read more